These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12951457)

  • 1. Cyclooxygenase inhibitors derived from thalidomide.
    Suizu M; Muroya Y; Kakuta H; Kagechika H; Tanatani A; Nagasawa K; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1098-102. PubMed ID: 12951457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide and its analogues as cyclooxygenase inhibitors.
    Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-phenylphthalimide-type cyclooxygenase (COX) inhibitors derived from thalidomide: substituent effects on subtype selectivity.
    Sano H; Noguchi T; Tanatani A; Miyachi H; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):1021-2. PubMed ID: 15305008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.
    Onn A; Tseng JE; Herbst RS
    Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841
    [No Abstract]   [Full Text] [Related]  

  • 6. Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxygenase-2 inhibitors.
    Rahim MA; Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2753-6. PubMed ID: 12217369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
    Cizmeciolu M; Pabuguoglu V; Ballar P; Pabuççuoğlu A; Soyer Z
    Arzneimittelforschung; 2011; 61(3):186-90. PubMed ID: 21528644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2205-9. PubMed ID: 12798335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of disubstituted 4,5-polymethylenepyrazoles as selective cyclooxygenase-2 inhibitors.
    Yu JW; Kim HH; Jahng Y
    Pharmazie; 2002 May; 57(5):301-5. PubMed ID: 12061251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors.
    Park CH; Siomboing X; Yous S; Gressier B; Luyckx M; Chavatte P
    Eur J Med Chem; 2002 Jun; 37(6):461-8. PubMed ID: 12204472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a better aspirin.
    Pennisi E
    Science; 1998 May; 280(5367):1191-2. PubMed ID: 9634399
    [No Abstract]   [Full Text] [Related]  

  • 13. Closing in on a stomach-sparing aspirin substitute.
    Service RF
    Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
    [No Abstract]   [Full Text] [Related]  

  • 14. QSAR analysis of some fused pyrazoles as selective cyclooxygenase-2 inhibitors: a Hansch approach.
    Prasanna S; Manivannan E; Chaturvedi SC
    Arch Pharm (Weinheim); 2004 Aug; 337(8):440-4. PubMed ID: 15293263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 16. Syntheses and biological evaluation of indole-2 and 3-carboxamides: new selective cyclooxygenase-2 inhibitors.
    Olgen S; Güner E; Fabregat MA; Crespo MI; Nebioğlu D
    Pharmazie; 2002 Apr; 57(4):238-42. PubMed ID: 11998441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors.
    Feixas J; Jiménez JM; Godessart N; Puig C; Soca L; Crespo MI
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2687-90. PubMed ID: 11591502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
    Penning TD; Talley JJ; Bertenshaw SR; Carter JS; Collins PW; Docter S; Graneto MJ; Lee LF; Malecha JW; Miyashiro JM; Rogers RS; Rogier DJ; Yu SS; AndersonGD ; Burton EG; Cogburn JN; Gregory SA; Koboldt CM; Perkins WE; Seibert K; Veenhuizen AW; Zhang YY; Isakson PC
    J Med Chem; 1997 Apr; 40(9):1347-65. PubMed ID: 9135032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of COX2 inhibitors.
    Flower RJ
    Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L.
    Oku H; Ishiguro K
    Biol Pharm Bull; 2002 May; 25(5):658-60. PubMed ID: 12033510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.